Medical Properties Trust, Inc. (NYSE:MPW) was upgraded by research analysts at JMP Securities from a “market perform” rating to an “outperform” rating in a report issued on Monday. The brokerage presently has a $14.00 price target on the real estate investment trust’s stock. JMP Securities’ target price points to a potential upside of 10.41% from the stock’s previous close. The analysts noted that the move was a valuation call.

Other equities research analysts have also issued research reports about the stock. ValuEngine lowered shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. BidaskClub upgraded shares of Medical Properties Trust from a “sell” rating to a “hold” rating in a report on Saturday, June 10th. Jefferies Group LLC upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and lifted their price objective for the company from $13.00 to $15.00 in a report on Friday, April 7th. Deutsche Bank AG lifted their price objective on shares of Medical Properties Trust from $13.50 to $15.00 and gave the company a “buy” rating in a report on Tuesday, July 4th. Finally, Royal Bank Of Canada reiterated a “buy” rating on shares of Medical Properties Trust in a report on Monday, May 15th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $14.20.

Medical Properties Trust (NYSE MPW) opened at 12.68 on Monday. The stock has a market cap of $4.07 billion, a PE ratio of 15.22 and a beta of 0.89. The firm has a 50 day moving average of $13.20 and a 200-day moving average of $12.96. Medical Properties Trust has a 52-week low of $11.54 and a 52-week high of $15.91.

Medical Properties Trust (NYSE:MPW) last released its earnings results on Thursday, May 4th. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.33. The firm had revenue of $156.40 million during the quarter, compared to analyst estimates of $156.91 million. Medical Properties Trust had a net margin of 41.79% and a return on equity of 7.94%. The business’s revenue was up 15.9% on a year-over-year basis. During the same quarter last year, the business earned $0.35 EPS. Equities analysts anticipate that Medical Properties Trust will post $0.86 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, July 14th. Stockholders of record on Thursday, June 15th were given a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.57%. The ex-dividend date of this dividend was Tuesday, June 13th. Medical Properties Trust’s payout ratio is currently 114.29%.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/medical-properties-trust-inc-mpw-upgraded-at-jmp-securities/1444358.html.

In related news, CFO R Steven Hamner sold 85,000 shares of Medical Properties Trust stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $13.36, for a total value of $1,135,600.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.00% of the stock is owned by insiders.

Hedge funds have recently added to or reduced their stakes in the company. Creative Planning boosted its stake in Medical Properties Trust by 0.7% in the second quarter. Creative Planning now owns 27,554 shares of the real estate investment trust’s stock worth $355,000 after buying an additional 185 shares during the period. Southeast Asset Advisors Inc. boosted its stake in Medical Properties Trust by 1.9% in the first quarter. Southeast Asset Advisors Inc. now owns 12,608 shares of the real estate investment trust’s stock worth $163,000 after buying an additional 230 shares during the period. Capstone Asset Management Co. boosted its stake in Medical Properties Trust by 1.0% in the second quarter. Capstone Asset Management Co. now owns 29,830 shares of the real estate investment trust’s stock worth $384,000 after buying an additional 290 shares during the period. Sheaff Brock Investment Advisors LLC boosted its stake in Medical Properties Trust by 2.6% in the first quarter. Sheaff Brock Investment Advisors LLC now owns 11,907 shares of the real estate investment trust’s stock worth $153,000 after buying an additional 303 shares during the period. Finally, Public Employees Retirement System of Ohio boosted its stake in Medical Properties Trust by 1.0% in the first quarter. Public Employees Retirement System of Ohio now owns 34,681 shares of the real estate investment trust’s stock worth $447,000 after buying an additional 360 shares during the period. Institutional investors own 78.45% of the company’s stock.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.